Led by CEO Harry Rowland, VahatiCor is developing the A-Flux coronary sinus reducer implant for coronary microvascular dysfunction.
As arts institutions struggle to increase attendance, entertainment centers marketed as museums are wooing those who once might have gone to view art. By Zachary Small and Tim F. Schneider The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results